When people can't afford rent, they often end up in closer quarters. NPR health policy correspondent Selena Simmons-Duffin shares two stories from her reporting and the research being done on housing and eviction policies in the US. For more of Selena's reporting, check out "Why helping people pay rent can fight the pandemic" (https://n.pr/3BIluHt).Follow Selena on Twitter @SelenaSD. You can email Short Wave at ShortWave@NPR.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Wissenschaft & Technik
Short Wave Folgen
New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong and Regina Barber for science on a different wavelength.If you're hooked, try Short Wave Plus. Your subscription supports the show and unlocks a sponsor-free feed. Learn more at plus.npr.org/shortwave
Folgen von Short Wave
1269 Folgen
-
Folge vom 04.11.2021Housing and COVID: Why helping people pay rent can help fight the pandemic
-
Folge vom 03.11.2021Planning for a space mission to last more than 50 yearsIn 1977, NASA sent out two Voyager probes to study Jupiter and Saturn. The spacecrafts were designed to last about five years, but they are still, to this day, collecting and sending back data from beyond the solar system. But the Voyager mission is living on borrowed time. Today NPR science correspondent Nell Greenfieldboyce talks about a proposal for an intentionally long mission - what it would take for NASA to actually plan for an interstellar voyage that would pass research and responsibility down through generations.What would you put on a spacecraft bound for the stars? Email the show at shortwave@npr.org!Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 02.11.2021A new step toward ending 'the wrath of malaria'Scientists have been trying to figure out how to eradicate malaria for decades. Globally, a child under the age of five dies from the disease every two minutes, and even for kids who do survive there can be long term complications. A big breakthrough finally came in October when the World Health Organization endorsed MoSQUIRIX, the first malaria vaccine. It has relatively low efficacy, just about 30%, but malaria researcher Winter Okoth explains how the new vaccine could still make a big difference.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 01.11.2021The history and future of mRNA vaccine technology (encore)(Encore) The Pfizer-BioNTech and Moderna COVID-19 vaccines are the first authorized vaccines in history to use mRNA technology. In light of the authorization for some children and teens now, we are encoring the episode in which Maddie Sofia chats with Dr. Margaret Liu, a physician and board chair of the International Society for Vaccines, about the history and science behind these groundbreaking vaccines. We'll also ask what we can expect from mRNA vaccines in the future. Have a question for us? Send a note to shortwave@npr.org — we'd love to hear it.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy